Dantrolene sodium can increase or attenuate activity of skeletal muscle ryanodine receptor calcium release channel. Clinical implications.
about
Subtype identification and functional characterization of ryanodine receptors in rat cerebral artery myocytes.Multiple Ca2+-dependent mechanisms regulate L-type Ca2+ current in retinal amacrine cells.Effects of azumolene on normal and malignant hyperthermia-susceptible skeletal muscle.Rescue of an in vitro neuron phenotype identified in Niemann-Pick disease, type C1 induced pluripotent stem cell-derived neurons by modulating the WNT pathway and calcium signalingEpidermal TRPM8 channel isoform controls the balance between keratinocyte proliferation and differentiation in a cold-dependent manner.Essential Role of Calmodulin in RyR Inhibition by Dantrolene.Effects of dantrolene on steps of excitation-contraction coupling in mammalian skeletal muscle fibers.Halothane modulation of skeletal muscle ryanodine receptors: dependence on Ca2+, Mg2+, and ATP.Reduced threshold for luminal Ca2+ activation of RyR1 underlies a causal mechanism of porcine malignant hyperthermia.Pharmacological distinction between dantrolene and ryanodine binding sites: evidence from normal and malignant hyperthermia-susceptible porcine skeletal muscle.In vivo Ca2+ dynamics induced by Ca2+ injection in individual rat skeletal muscle fibers.Organelle membrane derived patches: reshaping classical methods for new targetsMind the magnesium, in dantrolene suppression of malignant hyperthermia.Identification of a dantrolene-binding sequence on the skeletal muscle ryanodine receptor.Role for calcium from the sarcoplasmic reticulum in coupling muscle activity to nicotinic acetylcholine receptor gene expression in rat.Azumolene inhibits a component of store-operated calcium entry coupled to the skeletal muscle ryanodine receptor.Pharyngeal spasticity due to dantrolene
P2860
Q34085684-8595F1F2-A875-42A3-9398-31403621C29FQ34212882-5AF63B5C-76EC-4289-87F9-87CB0D5F1E82Q34719728-D4C605AD-4AF8-4144-8994-BB93BA4F922AQ35119670-31834601-E446-4C12-A46B-2169B0E513F0Q35665134-6079474C-56E4-4F93-9578-C836CFEC9DDBQ35745969-20C36961-C315-4C1E-A440-5BE2F99CA82AQ36444775-122CE505-9D67-4C14-A96D-6C640BCF34A4Q36768338-DE00B9D3-D2FC-47A4-BC78-FC971931C448Q39978369-7D3D9F7C-1297-4BB2-95B8-A8B69C9A885DQ41886433-D0CC50EF-49B1-471B-918D-5190E1249DF9Q42316489-B20AE464-A0DB-4EB3-A68D-AAF6C522DB5CQ42620650-90EB9051-6E4F-42A0-B309-FDE10812901FQ43083643-96229311-D8D3-4054-8B82-AD969F40E819Q44094526-B59C01C7-2EE4-4040-AC8F-3564F8DEC005Q47988668-83CF91E4-5276-4612-AF6B-A1107B5791BAQ48666234-7F73E825-DDF6-4D83-B8E4-EE279419A259Q58049720-3B215042-CD37-440E-ACBE-3BD5B94DF8D8
P2860
Dantrolene sodium can increase or attenuate activity of skeletal muscle ryanodine receptor calcium release channel. Clinical implications.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Dantrolene sodium can increase ...... hannel. Clinical implications.
@en
Dantrolene sodium can increase ...... hannel. Clinical implications.
@nl
type
label
Dantrolene sodium can increase ...... hannel. Clinical implications.
@en
Dantrolene sodium can increase ...... hannel. Clinical implications.
@nl
prefLabel
Dantrolene sodium can increase ...... hannel. Clinical implications.
@en
Dantrolene sodium can increase ...... hannel. Clinical implications.
@nl
P2093
P1433
P1476
Dantrolene sodium can increase ...... hannel. Clinical implications.
@en
P2093
P304
P356
10.1097/00000542-199606000-00013
P407
P577
1996-06-01T00:00:00Z